Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanLeukapheresisAntigens, CD34Combined Modality TherapyBlood Component RemovalBone Marrow TransplantationHematologic NeoplasmsGraft vs Host DiseaseMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsStem Cell TransplantationBusulfanTreatment OutcomeMyeloablative AgonistsLymphoma, Non-HodgkinHematopoietic Stem CellsGraft SurvivalThiotepaEtoposideAntineoplastic Agents, AlkylatingRemission InductionCytophagocytosisRecurrenceCarmustineIfosfamideStem CellsSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineHodgkin DiseaseNeoplasmsDisease-Free SurvivalRetrospective StudiesCord Blood Stem Cell TransplantationSurvival RateTissue DonorsImmunosuppressive AgentsTime FactorsLymphoma, T-CellTransplantation ChimeraDoxorubicinSurvival AnalysisWhole-Body IrradiationInfectionPlatelet CountCarboplatinBlood Cell CountHistocompatibilityPrednisoneDexamethasoneBone Marrow PurgingHistocompatibility TestingRecombinant ProteinsCytomegalovirus InfectionsLeukemia, Myeloid, AcuteFollow-Up StudiesBlood CellsAntineoplastic AgentsPOEMS SyndromeProspective StudiesVidarabineLeukemiaLymphomaFatal OutcomeTransplantation, IsogeneicFeasibility StudiesBlood Transfusion, AutologousLeukocytes, MononuclearImmunophenotypingGraft vs Leukemia EffectAnemia, AplasticT-LymphocytesOpportunistic InfectionsBlood DonorsCell SeparationMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesLymphocyte DepletionFlow CytometryBreast NeoplasmsFeverBone MarrowImmunomagnetic SeparationCyclosporinePrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensCells, CulturedHistiocytosis, Non-Langerhans-Cell